Allergan. (AGN) ROE - Return on Equity
Current and historical Return on Equity (ROE) values for Allergan. (AGN) over the last 10 years.
|Medical||Medical - Generic Drugs||$62.943B||$14.571B|
|Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.|